Implementing research findings in developing countriesBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7157.531 (Published 22 August 1998) Cite this as: BMJ 1998;317:531
- Paul Garnera, senior lecturer in international health (email@example.com),
- Rajendra Kaleb, neurologist,
- Rumona Dicksona, lecturer in research synthesis,
- Tony Dansc, associate professor,
- Rodrigo Salinasd, manager, district effectiveness project.
- a International Health Division, Liverpool School of Tropical Medicine, Liverpool L3 5QA
- b37 Shanwar, Pune 411 030, India
- cCollege of Medicine, University of the Philippines, 547 Pedro Gil, Metro Manila 1000, Philippines
- dDepartmento de Ciencias Neurologicas, Universidad de Chile, Avenida J M Infante 533, Santiago, Chile
- aCorrespondence to: Dr Garner
This is the last in a series of eight articles analysing the gap between research and practice
Series editors: Andrew Haines and Anna Donald
Developing countries have limited resources, so it is particularly important to invest in health care that works. The growing number of relevant systematic reviews can assist policymakers, clinicians, and consumers in making informed decisions. Developing countries have led the way in generating approaches to ensure professional standards of behaviour through interventions such as producing guidelines and introducing essential drug programmes, and by producing reliable research summaries to help ensure that policies are based on good evidence.
Financial resources are limited in developing countries so it is vital thatthe health care provided is effective
The number of systematic reviews relevant to developing countries is increasing
Disseminating the findings of systematic reviews to policymakers, health professionals,and consumers is an essential prerequisite to changing practices
Practice guidelines and international programmes that provide essential drugs are well established and provide a powerful route for reinforcing evidence based practice
Large obstacles impede the implementation of evidence based practices, such as the unethical promotion of drugs; these problems need to be addressed by regulation
Action is required at all levels of healthcare systems, from consumers through to health professionals, ministries of health, and international organisations
Yakamul, an illiterate villager in Papua New Guinea, was sitting by a fire listening to a health professional from the West tell her to take chloroquine throughout her pregnancy. She responded: “I ting merisin bilong ol wait man bai bagarapim mi [I think this Western medicine could harm me].” She had never attended a workshop in critical appraisal butshe realised that medicine could do her more harm than good. Her response reminds health professionals to ask fundamental questions about the care we provide and of our responsibility …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.